Specialist provider of bioscience laboratories

The Company is one of the UK’s leading providers of technical and regulatory advice for the design, construction and operation of Life Science and Healthcare facilities for leading Universities, Government Institutions and the NHS.

Typical projects range from Cell & Gene Therapy to Aseptic Pharma Units (GMP) Biocontainment (ACDP) and Biomedical facilities (ASPA).

Founded in 2012 the Company has established an enviable track record and its experience and reputation is trusted by leading institutions globally.

Building on the directors’ extensive experience and industry standing the company has developed a capable in-house team supported by quality assured systems and processes to deliver market leading performance.

Over 50 active blue-chip clients, 60% of whom provide reliable, repeat business.

Experienced professional workforce including field service, providing a wealth of in-house expertise with high staff retention.

Pipeline of current projects in the pipeline to the value of £2.5m from June 2024 to EO March 2027.

Life Sciences & Healthcare sectors are set for significant growth in the UK & Internationally with new build, refurb and replacement facilities.

Significant opportunity to develop leadership position in each sector including nascent CGT (Cell & Gene Therapy) market.

YE24 turnover of £1.2m with an adjusted EBITDA of £72k.

Average gross profit margin of 31% over the last three years.

Our clients are now offering the business for sale to facilitate further growth under the impetus of new ownership.

Offers invited.